SCHEMBL22985939

SCHEMBL22985939

COc1cc(C(=O)N2CCOCC2)ccc1Nc1nc2c(c(OC)n1)NCN2

nearest known ligand 0.69

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 20/20 0.69
▸ SLCO1B1 Q9Y6L6 1/20 0.61
▸ JAK2 O60674 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985912 0.90 LRRK2 (0.72) LRRK2JAK2
SCHEMBL7459229 0.81 LRRK2 (1.00) LRRK2
SCHEMBL14641949 0.81 LRRK2 (0.82) LRRK2JAK2
SCHEMBL31757153 0.81 LRRK2 (1.00) LRRK2SLCO1B1
SCHEMBL18018884 0.81 LRRK2 (1.00) LRRK2SLCO1B1
SCHEMBL7450050 0.81 LRRK2 (1.00) LRRK2JAK2
SCHEMBL7452897 0.81 LRRK2 (1.00) LRRK2JAK2
SCHEMBL31757155 0.80 LRRK2 (0.77) LRRK2SLCO1B1
SCHEMBL18018893 0.80 LRRK2 (1.00) LRRK2SLCO1B1
SCHEMBL31757156 0.80 LRRK2 (1.00) LRRK2SLCO1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3778604-A1 LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME Dana Farber Cancer Institute, Inc. (US) 2021-02-17 — — EP disclosed
EP-3778605-A2 LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME Dana Farber Cancer Institute, Inc. (US) 2021-02-17 — — EP disclosed
Send feedback